It seemed unfortunate timing for Oss-based biotech company RiboPro to launch its business on the eve of the corona crisis. But it turned out to be a winning move.
'Interleukin-33' can recognize viruses it has seen once before and signal the immune system to start producing antibodies.
A research team from Berlin's Charité University Hospital and MDC has shown how an antiviral messenger can favor the replication of the SARS-CoV-2 virus and allow the virus to spread.
Researchers from Munich and Ulm have shown how the novel coronavirus suppresses the immune response by disabling protein expression in the ribosomes.
The older a person gets, the more susceptible they are to disease. Relatively few people are fortunate enough to be able to stay healthy and […]
The Netherlands is busy adapting in all kinds of ways in order to deal with the corona pandemic. But are our corona measures effective at […]
The search for a vaccine against COVID-19 will take months, perhaps even years. Until that time, a drug that can combat the worst symptoms of […]
Selenium deficiency may play an important role as to how illness progresses following an infection with COVID-19. The mineral can be found in fish and […]
If the number of so-called lymphocytes in your blood is very low, then this is an indication that you may become gravely ill over time. […]
Over the past twenty years, nanoparticles have played an increasingly important role in medicine. They are used in drugs, e.g. for diseases such as Parkinson’s […]
Researchers at the Universities of Zurich (UZH) and Lausanne (UNIL) have now scientifically proven in a study what many people have been suspecting for a […]